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Abstract
While adult heart muscle is the least regenerative of tissues, embryonic cardiomyocytes are
proliferative, with embryonic stem (ES) cells providing an endless reservoir. In addition to
secreted factors and cell–cell interactions, the extracellular microenvironment has been shown
to play an important role in stem cell lineage specification, and understanding how scaffold
elasticity influences cardiac differentiation is crucial to cardiac tissue engineering. Though
previous studies have analyzed the role of matrix elasticity on the function of differentiated
cardiomyocytes, whether it affects the induction of cardiomyocytes from pluripotent stem
cells is poorly understood. Here, we examine the role of matrix rigidity on cardiac
differentiation using mouse and human ES cells. Culture on polydimethylsiloxane (PDMS)
substrates of varied monomer-to-crosslinker ratios revealed that rigid extracellular matrices
promote a higher yield of de novo cardiomyocytes from undifferentiated ES cells. Using a
genetically modified ES system that allows us to purify differentiated cardiomyocytes by drug
selection, we demonstrate that rigid environments induce higher cardiac troponin T
expression, beating rate of foci, and expression ratio of adult α- to fetal β- myosin heavy chain
in a purified cardiac population. M-mode and mechanical interferometry image analyses
demonstrate that these ES-derived cardiomyocytes display functional maturity and
synchronization of beating when co-cultured with neonatal cardiomyocytes harvested from a
developing embryo. Together, these data identify matrix stiffness as an independent factor that
instructs not only the maturation of already differentiated cardiomyocytes but also the
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induction and proliferation of cardiomyocytes from undifferentiated progenitors. Manipulation
of the stiffness will help direct the production of functional cardiomyocytes en masse from
stem cells for regenerative medicine purposes.
Keywords: cardiac differentiation pluripotent embryonic stem cell matrix elasticity,
drug-selected cardiomyocyte, synchronization, mechanical interferometry
S Online supplementary data available from stacks.iop.org/STAM/14/025003/mmedia
1. Introduction
Stem cell lineage specification is regulated by three
types of inductive signal: soluble factors secreted by
cells that diffuse through extracellular fluid, cell–cell
interactions that vary within a complex multicellular
organism, and extracellular matrix (ECM). Soluble growth
factors and cell membrane-bound factors such as PDGF,
TGF-β, VEGF, BMP and Notch signaling have been
implicated as having multivariable effects on cardiac
development [1–3]. Insoluble ECM proteins are also known
to affect the microenvironmental cues during cardiovascular
development [4, 5]. Such developmental cues have been
intensely exploited in traditional tissue culture methods
to simulate a biological process in vitro. However, recent
work has also suggested the relevance of a fourth
factor—interactions between the stem cell and its physical
microenvironment.
In the living organism, adult stem cells, as part of
regenerative or developmental processes are believed to egress
away from their native environment and embed themselves
within a range of tissue microenvironments to facilitate
maturation [6]. For example, naı¨ve mesenchymal stem cells
(MSCs) show extreme sensitivity to tissue-level elasticity
when cultured under various microenvironments [7]. The
cell lineages differentiating from MSCs is known to reflect
the extracellular microenvironment in terms of elasticity;
soft matrices mimicking brain tissue and rigid matrices
resembling bone, for example, are neurogenic and osteogenic,
respectively. While several studies have discerned how the
physical microenvironment influences the phenotype and
behavior of mature cardiomyocytes [8–11], little is known
about its role in determining the cardiac lineage from an
undifferentiated state.
Here, we investigated the role of matrix elasticity on
cardiac lineage specification from undifferentiated pluripotent
stem cells. These forces are quantified by the elastic
modulus (E). While some reported the typical range
expected for high-yield myogenic lineage specification to
be between 1 and 20 kPa [12], others have reported
that neonatal cardiomyocytes demonstrate the greatest
contractile function on very rigid matrices [9, 10]. To
recapitulate the varied matrix elasticities of these extracellular
environments, we coated standard tissue-culture plates with
polydimethylsiloxane (PDMS), an elastic and chemically
inert siloalkane polymer, of synthetically tunable stiffness.
Embryoid bodies (EBs) representative of in vivo growth
conditions were plated onto these synthetic substrates,
monitored for emergence of the cardiac lineage, and
scored for cardiomyocyte activity using several quantitative
methods. In all cases, the growth and lineage specification
of mouse and human pluripotent stem cells showed a
relative dependence on substrate elasticity, whereby the
highest yield of cardiomyocytes occurred under the rigid
microenvironmental conditions of the standard tissue culture
plate. This effect was also observed in the culture of a
more select population of ES-derived cardiomyocytes, which
was purified using a genetic drug selection system [13].
Together, such findings give insight into the role of the
gradually stiffening physical microenvironment in cardiac
development and the potential uses of ES and iPS cells for
tissue engineering purposes.
2. Materials and methods
2.1. Elastic substrate synthesis
PDMS substrates of 0.5 cm thickness were created in standard
six-well tissue culture plates according to the manufacturer’s
specifications (Dow Corning). Briefly, various ratios of
PDMS base-to-crosslinking agent (either 10:1 or 50:1) were
mixed to alter the substrates’ elastic modulus, degassed for
30 min to prevent bubble formation, and cured at 65 ◦C
for 3 h. The PDMS was then soaked in molecular biology
grade 95% ethanol overnight to extract unwanted siloxane
monomers. Both PDMS and standard tissue culture substrates
were treated with oxygen plasma for 30 s for sterilization
and uniform surface modification. Elastic moduli (E) were
determined before and after 2D culture in liquid media using
plate-to-plate rheometry.
2.2. Mouse ES cell culture and differentiation
Undifferentiated wild type mouse E14Tg2a (ATCC) cells and
Nkx2-5neoR/+ mouse ES [13] cells were maintained on mouse
embryonic fibroblast feeder cells in high-glucose Dulbecco’s
modified Eagle medium (DMEM, Gibco) supplemented with
15% fetal calf serum (FCS), 1×non-essential amino acids
(Invitrogen), 25 mmol L−1 HEPES, 2 mmol L−1 l-glutamine,
0.1 mg ml−1 penicillin/streptomycin, 0.1 mmol L−1
2-mercaptoethanol and 1000 U ml–1 leukemia inhibitory
factor (LIF, ESGRO-TM, Chemicon International, Inc.).
ES cells were differentiated in hanging drops (600 cells
per 20µl−1) without LIF under non-adherent conditions.
E14Tg2a wild type (day 2) and Nkx2-5neoR/+ (day 5)
embryoid bodies (EBs) were plated onto PDMS and standard
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tissue culture dishes coated with 10µg ml–1 fibronectin
(Sigma). Media were changed every 2 days during adherent
culture. Nkx2-5neoR/+ EBs were purified by adding G418
neomycin antibiotic (600µg ml–1) for 6 days.
2.3. Human ES cell culture and differentiation
Human H1, H9 (WiCell) and UCLA1-6 (UCLA stem cell
core) [14] ES cells were grown on mouse embryonic
fibroblast feeder in DMEM (Gibco) media supplemented
with 20% knockout (KO) serum replacement (Gibco) and
8 ng ml–1 bFGF (Sigma). EBs were differentiated according
to previous reports with minor modification [15]. Briefly,
human ES cells were dissociated with TrypLE Select
(Invitrogen) for 5 min and 20 000 human ES cells were
differentiated in StemPro 34 (Gibco) supplemented with
10µM Y27632 (Rho kinase inhibitor IV, EMD Chemicals),
3 ng ml−1 Activin A (Peprotech), 5 ng ml−1 bFGF, 10 ng ml−1
BMP4 (Peprotech) and 5µM IWR-1 (EMD Chemicals),
for the first 4 days. EBs were then cultured in StemPro
34 supplemented with 10 ng ml−1 bFGF, 5 ng ml–1 vascular
endothelial growth factor (VEGF, Peprotech) and 5µM
IWR-1 for 5 additional days before plating onto elastic
substrates. Usage of all human ES cell lines is approved
by the UCLA Embryonic Stem Cell Research Oversight
(ESCRO) Committee and the Institutional Review Boards
(IRB, approval #2009-006-04).
2.4. Preparation of neonatal cardiomyocytes
Neonatal hearts were dissected, washed in HBSS, and
bathed in 0.5 mg ml−1 trypsin-HBSS overnight at 4 ◦C for
pre-digestion as previously described [16]. The heart tissues
were then washed in warm medium and digested with
0.5 mg ml−1 type II collagenase (Worthington Corp.) in HBSS
for 10 min at 37 ◦C for four times. Dissociated cells then
underwent two rounds of differential plating onto plastic
tissue culture dishes for 1 h at 37 ◦C and 5% CO2 to remove
adherent non-cardiomyocytes. Non-adherent cardiomyocytes
were then plated onto tissue culture dishes coated with
10µg ml–1 fibronectin at 75% confluency prior to co-culture
with ES-derived cardiomyocytes. All experiments were
performed following the guidelines and protocol approved
by the Animal Research Committee for care and use of
laboratory animals (Animal Research Committee approval
#2008–143-11B).
2.5. Quantifying cardiac proliferation and function
Single cells were isolated from EB culture via trypsinization,
fixed with 0.5% PFA, and analyzed for expression of cardiac
troponin T (cTnT). The relative abundance of cells was
quantified with by FACS analysis using BD∗LSR FACS
Diva for PE-conjugated rabbit anti-mouse cTnT primary
antibody. Extracellular staining was performed by blocking
the cells with a 0.1% saponine 3% FCS/PBS buffer, labeled
with a 1:500 dilution of rabbit anti-cTnT antibody, and
conjugated with 1:1000 dilution of anti-rabbit PE antibody.
mRNA transcription profiles for cardiac troponin T (cTnT),
alpha myosin heavy chain (α-MHC), and beta myosin heavy
chain (β-MHC) was performed on cDNA reverse transcribed
from mRNA collected from EB cultures at day 10 for wild
type cells or day 16 for Nkx2-5neoR/+ cells. qRT-PCR was
performed using the following primer designs:
Mouse cTnT: forward: 5′ GGAAATAGATGAAA-
CTGTC; reverse: 5′ GCTCCCACTATCCAAAC,
Mouse α-MHC: forward: 5′ GAGATTTCTCCAA-
CCCAG; reverse: 5′ TCTGACTTTCGGAGGTACT,
Mouse β-MHC: forward: 5′ CTACAGGCCTGGGC-
TTACC; reverse: 5′ TCTCCTTCTCAGACTTCCGC,
Human cTnT: forward: 5′ CAGAGCGGAAAAGTGG-
GAAGA; reverse: 5′ TCGTTGATCCTGTTTCGGAGA.
All expression values were quantitatively normalized by
expression of the GAPDH housekeeping gene. Relative
expression values were calculated using the delta–delta Ct
method [17].
2.6. Transplantation of ES-derived cardiac foci
After culture and drug selection until day 16, EBs were
washed with trypsin for 2 min to facilitate dissociation from
the substrate surface and transferred into a small conical
tube. Light centrifugation was performed for 5 min until
individual EBs were reseeded onto a new layer of neonatal
cardiomyocytes that were in culture for 5 days in ES media
without LIF and neomycin.
2.7. Analysis of cardiac synchronization
Synchronization between ES-derived and neonatal
cardiomyocytes post-transplantation was examined both
by M-mode image analysis and mechanical interferometry
imaging (MII) [18]. M-mode image analysis was performed
using customized software [19] on videos of beating
cardiomyocytes in culture obtained using a Sony HDR-SR11
camcorder. MII was performed by culturing cells on silicon
substrates and subsequent observation under a Michelson
interferometer with an adjustable mirror in the reference
arm to permit measurements in the media-filled observation
chamber. Areas of interest were selected and analyzed for
vertical motion through changes in interference pattern using
a customized image-processing algorithm using MATLAB.
3. Results
3.1. PDMS substrates model physical microenvironments of
varied matrix elasticity
While several elastomeric substrates have been used for
the analyses of the role of matrix elasticity of the
behavior of the cells, we selected PDMS for its modifiable
surface properties, ease of synthesis, biocompatibility with
mammalian cell culture, and established use [20, 21].
PDMS substrates were synthesized on six-well tissue culture
plates according to manufacturer’s instructions. Scaffolds
of varying stiffness were created using different ratios
of the PDMS base-to-curing agent, rinsed with ethanol
overnight to extract siloxane monomers, and O2 plasma
3
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Figure 1. Experimental design for ES stiffness culture. (A) Elastic modulus of PDMS substrates of varying base-to-curing-agent ratio were
rheometrically characterized before and after culture in liquid media relative to 3 GPa standard TC plate. ES cells are formed into EBs via a
hanging drop method, marking the onset of differentiation and (B) landed onto substrates. (C) EBs show similar adhesion profile to PDMS
and tissue culture plates. All culture conditions show greater than 85% adhesion of individual EBs with no statistically significant difference
between groups (p > 0.05).
treated for uniform surface chemistry prior to culture. We
related the PDMS base-to-curing agent ratio to the elastic
modulus (E) both before and after cell culture in liquid
media using rheometry, and a nonlinear relationship was
established in accord with previously reported data [22]. Only
substrates corresponding to an elastic modulus of ∼1000
(10:1 PDMS base-to-crosslinking agent) and ∼10 kPa (50:1
PDMS base-to-crosslinking agent) were used for experiments
(figure 1(A)). Standard polystyrene tissue culture (TC) plates
were used to recapitulate a high stiffness environment, with
an elastic modulus on the order of 3 GPa [9].
Mouse EBs were then landed onto 2D culture
environments for differentiation after several days
(figure 1(B)). Although the PDMS substrates are hydrophobic,
fibronectin coating appeared to mitigate this effect, as each
condition showed a similar adhesion profile (figure 1(C)).
Moreover, EBs showed comparable morphologies and
differentiation profiles when cultured on either PDMS or
standard TC plates.
3.2. Rigid substrates promote induction of cardiomyocytes
from an undifferentiated state
Using this culture setup, we sought to quantify the effect of
the stiffness of the extracellular matrix on cardiac lineage
specification of undifferentiated ES cells. With our hands,
mouse ES cells start to differentiate into cardiac, vascular
and hematopoietic lineage as early as day 4 after formation
of EBs in hanging drop culture [23, 24]. At 2 days of
differentiation, when mouse ES cells are not yet committed
to cardiac lineage, EBs were plated onto fibronectin-coated
2D substrates of varying stiffness: the rigid TC plate, 10:1
PDMS, and 50:1 PDMS (figure 2(A)). They were maintained
in a differentiation culture medium and observed until day 10,
at which point cells were dissociated and collected for
further analysis. EBs adherent to PDMS substrates started
to spontaneously beat and express cTnT with clear striation
patterns at day 8 (figure 2(B)).
To quantitatively determine the relative number of
cardiomyocytes, fluorescence-activated cell sorting (FACS)
analysis was performed on cultured cells fluorescently
stained for intracellular expression of cTnT (figure 2(C)).
EBs cultured on substrates softer than the traditional
tissue culture plates yielded fewer cTnT+ cells than those
grown on standard, highly-stiff culture plates (figure 2(D)).
Consistently, qRT-PCR showed the highest cTnT expression
relative to the GAPDH housekeeping gene on a rigid
substrate (figure 2(E)). A previous study reported that
fully-differentiated murine cardiomyocytes show enhanced
functional maturation in beating rate and contractile force
on an extremely rigid substrate [9]. Our data further
demonstrate that a rigid environment enhances the induction
of cardiomyocytes from undifferentiated ES cells.
We next examined whether matrix stiffness also regulates
the cardiac differentiation of human ES cells. As human
ES cell lines display tremendous variability in their lineage
differentiation capabilities, we first tested eight human ES
cell lines for their cardiac differentiation efficiency. H1, H9
and UCLA1-6 human ES cell lines were differentiated in
EBs using Wnt inhibitor [15], and cardiac differentiation was
examined at day 15 by FACS analysis for the expression of
cardiac specific myosin using MF20 antibody. Among human
ES cell lines tested, H9 and UCLA4 consistently showed
efficient cardiac induction (figures 2(F), and (G)), and hence
the effect of the matrix rigidity was examined using these
two cell lines. Cardiomyocytes were induced from H9 and
UCLA4 EBs using Wnt inhibitor [15] for 5 days and plated on
matrices of varied rigidity for 10 days. qRT-PCR showed that
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Figure 2. Undifferentiated ES cells show greatest cardiac differentiation on rigid substrates. (A) Timeline of culture and analysis of
ES-derived cardiomyocytes from stiffness culture. (B) Fluorescent staining of cTnT (green) on adherent EBs shows organized striation
patterns and is a suitable marker for analysis. (C) Representative FACS analysis profiles and (D) cumulative data of cTnT+ cells demonstrate
a correlation between high rigidity and cardiac proliferation from a pluripotent state (n = 5). (E) qRT-PCR analysis of cultured cells for
cTnT mRNA expression relative to GAPDH shows that the rigidity of the 2D substrate determines cardiac induction in both murine (n = 4)
and human (n = 3) ES cell lines. FACS quantification of MF20+ cells in day 15 EB generated from indicated human ES cell lines (F).
Representative FACS profiles show induction of MF20+ cardiomyocytes at day 15 of EB formation (G). All values are mean ±SD,
where ∗ indicates p-value < 0.05 and ∗∗ indicates p-values < 0.01.
stiffer substrates also induce stronger cardiac differentiation
in human ES cell models (figure 2(E)). Thus, human ES cells
respond to matrix elasticity similarly to mouse ES in vitro
differentiation models.
3.3. Rigid matrices promote differentiation of functional
cardiomyocytes at later stages
One limitation of the ES in vitro differentiation system is that
it generates various cell types simultaneously. To ascertain the
effect of matrix stiffness on the differentiation and function
of a purified cardiac population, we next employed a drug
selection method using Nkx2-5neoR/+ knockin ES cells, in
which the neomycin resistance gene is targeted into the
cardiac specific Nkx2-5 allele [13]. This drug selection
system yields purified beating cardiac foci with enrichment
of multiple downstream targets of Nkx2-5, including ANF,
Mlc2v and HOP. Such high yields are particularly important
for the efficient production of functional cardiac tissue
en masse for regenerative medicine purposes.
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Figure 3. Nkx2-5 drug-selected cardiomyocytes show greatest cardiac maturation on rigid substrates. (A) Nkx2-5neoR/+ ES cells were
formed into EBs, landed onto PDMS and/or TC plate substrates, and subjected to drug selection. After 6 days under neomycin selection,
ES-derived cardiac foci showed greater maturity on rigid matrices via (B) cTnT mRNA expression relative to GAPDH (n = 3) and (C)
beating rate (n = 3). Cardiac foci also demonstrated a higher expression of adult α-MHC relative to fetal β-MHC, verifying their mature
cardiac phenotype (D). Expression analyses of MLC2v (ventricular myocytes) and SLN (atrial myocytes) indicate that rigid and soft
environments induce ventricular and atrial myocytes, respectively (n = 3) (E). MLC2v and SLN expression levels are normalized to those
of 50:1 and TC plate, respectively. All values are mean ± SD, where ∗ indicates p-value < 0.05 and ∗∗ indicates p-value < 0.01.
Nkx2-5neoR/+ EBs were formed via a hanging drop
method, landed onto substrates at day 5, and cultured with
neomycin at day 10 (figure 3(A)) for 6 days, resulting
in the detachment of all non-cardiac lineages and the
selective enrichment of beating cardiomyocyte populations
(supplementary video 1, available from stacks.iop.org/STAM/
14/025003/mmedia). qRT-PCR from drug-selected
cardiomyocytes indicated that cTnT expression was higher
on the rigid substrates (figure 3(B)). We also observed the
highest beating rate in cells cultured on the extremely rigid
TC plate substrate, with rates of up to 100 bpm (figure 3(C)).
Although suggestive, the beating rate of ES-derived
cardiomyocytes alone is not an accurate indicator of
cardiac maturation. To further examine whether stiffer
environments improve the functional maturity of ES-derived
cardiomyocytes, we examined the relative expression of
two differentially expressed isoforms of the myosin heavy
chain (MHC) contractile protein, α-MHC and β-MHC. In
mice, the α-MHC gene is predominantly expressed in the
adult myocardium and is 4 kilobases upstream of β-MHC,
which is expressed only during late fetal life [25]. The
relative expression of these two genes is tightly controlled
and indicative of the maturity of the cardiomyocytes.
Misregulation of the ratio of α and β-MHCs, known as fetal
gene reactivation, has been correlated with a wide variety
of pathological conditions of the heart including hypertrophy
and infarction [26, 27]. qRT-PCR analysis of these two genes
showed that cardiomyocytes derived from drug selection
and culture on more rigid substrates have the highest
α/β-MHC expression ratio (figure 3(D)). Interestingly,
expression analyses of chamber-specific markers revealed
that MLC2v+ ventricular myocytes are strongly induced
in rigid environments whereas SLN+ atrial myocytes are
dominant in softer environments (figure 3(E)), indicating
that matrix elasticity induces the cardiac differentiation in
an atrial-ventricular lineage specific manner. Together, these
results suggest that increased microenvironmental stiffness
not only promotes differentiation of cardiomyocytes but also
supports their functional maturation at later stages.
3.4. ES-derived cardiac foci display functional synchrony
with native cardiomyocytes
To test the functionality of these cultured cardiomyocytes, we
transplanted the ES-derived cardiac foci at day 16 of drug
selection onto a layer of neonatal cardiomyocytes obtained
from the hearts of newborn mice and imaged using light
microscopy (figure 4(A)). The onset of synchronized beating
between these two cell types suggests that the cells may be
transplantable and useful for tissue regeneration purposes and
medical therapeutics. Here, we observed that drug-selected
cardiomyocytes transplanted from TC plate, 10:1 PDMS and
50:1 PDMS stiffness conditions electrically coupled with
neonatal cardiomyocytes for synchronized beating between
the EB and neonatal cardiomyocyte (CM), as observed
visually and confirmed via M-mode image analysis of
contractile frequency pattern in each region (figures 4(B)
and (C)).
Mechanical interferometry imaging (MII), a recently
developed real-space technique for the quantitative detection
6
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Figure 4. Transplanted cardiomyocyte foci display synchrony with the neonatal cardiomyocyte feeder layer. Cardiac foci derived from
drug-selection (EB) and stiffness culture were transplanted onto a monolayer of neonatal cardiomyocytes (CM) at day 16, as shown in
figure 3(A). (A) Representative light microscopic image of EB cultured on CM. The M-mode image was obtained at the red line. (B), (C)
After 2 days, M-mode image analysis of videos of co-cultured samples confirms synchronization of beating frequency between EB (B) and
neonatal cardiomyocyte (C) layers. Beating is largely regular with minor arrhythmia. (D)–(F) MII analyses at the beating regions of EBs
transplanted onto CM (D). EB and CM initially beat asynchronously (E), but become fully synchronized after 48 h in co-culture (F).
of nanoscale mechanical displacements, was used to confirm
the electrical coupling between ES-derived and neonatal
cardiomyocytes [18]. In this setup, cells were cultured on
silicon substrates in a custom-built fluid compensation cell
maintained at 37 ◦C and 5% CO2 for real-time imaging
of the vertical movement of cardiac foci while in culture.
Under MII, clustered cells of EBs normally appear dark
and become lighter when vertical heights change, while
individual neonatal cardiomyocytes change from light to
dark upon contraction (figure 4(D), supplementary video
2, available from stacks.iop.org/STAM/14/025003/mmedia).
MII analyses of cultured cells revealed that ES-derived
and neonatal cardiomyocytes initially beat asynchronously
(figure 4(E)), and become fully synchronized after 48 h in
co-culture (figure 4(F), supplementary video 2).
4. Discussion
Collectively, these data suggest that rigid extracellular
matrices support the differentiation of pluripotent ES cells
into functional cardiomyocytes in two ways: cardiac lineage
induction and functional maturation. This paper is, to our
knowledge, the first report of the role of matrix elasticity in
de novo cardiogenesis from undifferentiated ES cells, and the
first demonstration of mechanical interferometry imaging as a
tool for microscale characterization of cardiac differentiation
and maturation.
Previous studies have demonstrated the influence of
the physical microenvironment on the function of already
differentiated cardiomyocytes isolated from embryos or ES
cells [9, 11]. Differentiated cardiomyocytes isolated from
7
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embryonic hearts function best in matrices even stiffer
than normal physiological myocardium [8, 9]. Our findings
are in accordance with these reports in that drug selected
differentiated cardiomyocytes display highest α/β-MHC
expression when cultured on TC plates (figure 3). Although
higher stiffness may represent the scar tissue in the infarcted
heart [8], data from this group (figure 3) and others
[9, 11] demonstrate that superphysiological rigidity serves to
the better function of differentiated cardiomyocytes isolated
from embryos and human ES cells.
While these previous studies used already differentiated
cardiomyocytes as starting material and examined their
function, the novelty of our report is the observation
that a stiffer environment enhances not only the function
of the already differentiated cardiomyocytes but also the
de novo induction of mouse and human cardiac specification
at uncommitted stages. Cardiac progenitors contribute to
the embryonic myocardial tube in two waves: while the
progenitors in the classical cardiac crescent (first heart
field) form the future left ventricle first, multipotent cardiac
progenitors in the extra crescent (second heart field) migrate
later to the heart tube and add additional myocardia that
contribute to the future atria and outflow tract. These
late-migrating second heart field progenitors maintain their
multipotency until later stages [16, 23, 24], and gradually
lose plasticity and differentiate in the relatively rigid scaffold
provided by already maturated myocardium. This creates
a unique interaction between the late-migrating immature
cardiac progenitors and already mature myocardium. This
unique in vivo cardiac maturation process seems to be
reflected in our finding that a stiffer environment favors
cardiac specification of ES cells. Our results imply that
early waves of cardiomyocytes induce the differentiation
of the late-migrating second heart field progenitors in
part via their stiffer biophysical environment. While the
cardiomyocytes mature to generate unique biophysical
activities, the biophysical cues in turn appear to promote
reciprocally maturation of the cardiac progenitors.
It is not clear at the moment why the de novo cardiac
induction was most efficient in superphysiological conditions.
Further understanding of how the biophysical cues are
translated into molecular mechanisms during the cardiac cell
fate specification would be useful for discerning the role of
physical cues in embryonic stem cell fate determination [28],
and improving cardiac tissue culture methods for future
application in regenerative medicine.
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